Lanreotide Acetate
- Product NDC
- 69097-870
- 11-digit product format
- 690970870
- Labeler code
- 69097
- Product ID
- 69097-870_fd205110-15eb-4707-82b2-185e5bbf616b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lanreotide acetate
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- Cipla USA Inc.
- Application
- NDA215395
- Marketing category
- NDA
- Marketing start
- 2021-12-24
- Substance
- LANREOTIDE ACETATE
- Active strength
- 120 mg/.5mL
- Pharmacologic classes
- Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lanreotide Acetate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LANREOTIDE ACETATE | 120 mg/.5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | IEU56G3J9C |
| Rxcui | 749811, 749814, 749817 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69097-870-67 | Lanreotide Acetate | 1 in 1 CARTON | INJECTION | 1 | | 7 |
| 69097-870-67 | Lanreotide Acetate | 0.5 mL in 1 SYRINGE | INJECTION | 0.5 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-870 | LANREOTIDE ACETATE INJECTION [CIPLA USA INC.] | 7 | Current NDC, Legacy NDC, 2 package rows | 20240925_11da176a-99bc-4ada-8b3f-6bd2b37a6313.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-870-67 | 69097087067 | 1 SYRINGE in 1 CARTON (69097-870-67) / .5 mL in 1 SYRINGE | 1 syringe | 2021-12-24 | 0000-00-00 | No | No | Current |